Low risk of haematomas with intramuscular vaccines in anticoagulated patients: a systematic review with meta-analysis
Abstract Introduction The summary of product characteristics of vaccines administered intramuscularly, including the vaccine for coronavirus SARS-CoV-2 (COVID-19) and Influenza, warned for risks of bleeding in patients treated with oral anticoagulants. We aimed to estimate the incidence of major ble...
Main Authors: | Daniel Caldeira, Bárbara Sucena Rodrigues, Mariana Alves, Fausto J. Pinto, Joaquim J. Ferreira |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-02-01
|
Series: | Thrombosis Journal |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12959-022-00367-1 |
Similar Items
-
Characteristics of bleeding complications in patients with anticoagulant treatment
by: Swiss Medical Weekly
Published: (2008-11-01) -
Prothrombin complex concentrate versus placebo, no intervention, or other interventions in critically bleeding patients associated with oral anticoagulant administration: a protocol for a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis
by: Christian Ovesen, et al.
Published: (2018-10-01) -
Spontaneous Resolution of Non Traumatic Chronic Subdural Haematoma Despite Continued Antiplatelet Therapy: A Case Report
by: Ajeet Ramamani Tiwari, et al.
Published: (2015-06-01) -
Knowledge, attitudes, beliefs, and barriers associated with the uptake of influenza vaccine among pregnant women
by: Ahmed Y. Mayet, et al.
Published: (2017-01-01) -
Massive iliopsoas haematoma during the course of COVID‐19 pneumonia
by: Hiroaki Nagano, et al.
Published: (2023-01-01)